# Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis

> **NCT00205647** · PHASE2 · COMPLETED · sponsor: **Wake Forest University** · enrollment: 240 (—)

## Conditions studied

- Chronic Bronchitis

## Interventions

- **DRUG:** Oral N-acetycystein (NAC)

## Key facts

- **NCT ID:** NCT00205647
- **Lead sponsor:** Wake Forest University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-01
- **Primary completion:** —
- **Final completion:** 2000-03
- **Target enrollment:** 240 (—)
- **Last updated:** 2017-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00205647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00205647, "Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00205647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*